Clinical study of and questionnaire on hypnotherapy for relieving pain in patients with cancer
-
摘要:
目的 研究催眠疗法治疗癌痛的有效性，了解医护人员和患者对催眠疗法治疗癌痛临床应用的认知与需求。 方法 回顾性选取2020年1月至2020年12月于华中科技大学同济医学院附属同济医院招募罹患癌症且伴有疼痛的患者120例，进行8周的认知催眠治疗。比较癌痛患者接受催眠治疗2、4、8周后疼痛数字评分（NRS）、汉密尔顿焦虑量表（HAMA）评分、汉密尔顿抑郁量表（HAMD）评分及睡眠量表（MOS-SS）评分的变化；设计《催眠疗法治疗癌痛认知与需求调查问卷》，对2020年6月至2020年9月住院的354例癌痛患者和301名肿瘤科医护人员展开调查。 结果 120例癌痛患者参与了催眠治疗并完成了2周的评估，109例（90.8%）完成8周的治疗评估。催眠治疗2、4、8周后，NRS评分显著下降（P<0.05）；催眠治疗4、8周后，HAMA、HAMD评分显著下降（P<0.05），MOS-SS评分显著升高（P<0.05）。84.1%的医护人员认为有必要常规开展认知催眠治疗；64.4%的癌痛患者能接受催眠治疗。 结论 催眠疗法可以减轻癌痛，同时降低癌痛患者的焦虑、抑郁情绪，改善患者睡眠状况；加强医护人员和患者的宣传教育对催眠疗法的临床应用具有重要意义。 Abstract:Objective To assess the efficacy of hypnotherapy in relieving the pain of patients with cancer and determine the cognition and demand of medical staff and patients to conduct hypnosis. Methods Overall, 120 patients with cancer pain admitted to Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology from January 2020 to December 2020 were enrolled. The participants were treated with cognitive hypnosis for 8 weeks. The Numeric Rating Scale (NRS), Hamilton Depression Rating Scale (HAMD), and Hamilton Anxiety Rating Scale (HAMA) scores and Medical Outcomes Study Sleep Scale (MOS-SS) scores of patients with cancer pain were evaluated after 2, 4, and 8 weeks of hypnotherapy. In total, 354 patients with cancer pain and 301 medical staff in this research programme took the questionnaire on cognition of and demand for hypnotherapy for cancer pain from June 2020 to September 2020. Results Overall, 120 patients with cancer pain received hypnotherapy and completed the 2-week evaluation, among whom 109 (90.8%) completed the 8-week evaluation. NRS scores significantly decreased after 2, 4, and 8 weeks of hypnotherapy (P<0.05). HAMA and HAMD scores significantly decreased (P<0.05) and MOS-SS significantly increased (P<0.05) after 4 and 8 weeks of hypnotherapy. Furthermore, 84.1% of the oncology medical staff believed that it was necessary to provide routine hypnotherapy for cancer pain, while 64.4% of patients with cancer pain responded that they would like to receive hypnotherapy. Conclusions Hypnotherapy could relieve pain and improve anxiety, depression, and sleep statuses of patients with cancer. Strengthening hypnotherapy education for medical staff and patients with cancer is of great importance for the clinical application of hypnotherapy for cancer pain. -
Key words:
- hypnotherapy /
- cancer pain /
- efficacy /
- clinical application
-
[1] 中国抗癌协会癌症康复与姑息治疗专业委员会难治性癌痛学组,中华医学会疼痛学分会癌痛学组.癌性爆发痛专家共识(2019年版)[J].中国肿瘤临床,2019,46(6):267-271. doi: 10.3969/j.issn.1000-8179.2019.06.228 [2] Kirsch I, Montgomery G, Sapirstein G. Hypnosis as an adjunct to cognitive-behavioral psychotherapy: a meta-analysis[J]. J Consult Clin Psychol, 1995, 63(2):214-220. doi: 10.1037/0022-006X.63.2.214 [3] Elkins GR, Barabasz AF, Council JR, et al. Advancing research and practice: the revised APA Division 30 definition of hypnosis[J]. Int J Clin Exp Hypn, 2015, 63(1):1-9. doi: 10.1080/00207144.2014.961870 [4] 中国抗癌协会肿瘤麻醉与镇痛专业委员会.中国肿瘤患者围术期疼痛管理专家共识(2020版)[J].中国肿瘤临床,2020,47(14):703-710. doi: 10.3969/j.issn.1000-8179.2020.14.584 [5] Maindet C, Burnod A, Minello C, et al. Strategies of complementary and integrative therapies in cancer-related pain-attaining exhaustive cancer pain management[J]. Support Care Cancer, 2019, 27(8):3119-3132. doi: 10.1007/s00520-019-04829-7 [6] Tonye-Geoffroy L, Mauboussin Carlos S, Tuffet S, et al. Efficacy of a combination of hypnosis and transcutaneous electrical nerve stimulation for chronic non-cancer pain: a randomized controlled trial[J]. J Adv Nurs, 2021, 77(6):2875-2886. doi: 10.1111/jan.14833 [7] Zanardi R, Franchini L, Serretti A, et al. Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study[J]. J Clin Psychiatry, 2000, 61(1):26-29. doi: 10.4088/JCP.v61n0107 [8] Russo MM, Sundaramurthi T. An overview of cancer pain: epidemiology and pathophysiology[J]. Semin Oncol Nurs, 2019, 35(3): 223-228. [9] Fink RM, Gallagher E. Cancer pain assessment and measurement[J]. Semin Oncol Nurs, 2019, 35(3): 229-234. [10] Portenoy RK, Ahmed E. Cancer pain syndromes[J]. Hematol Oncol Clin North Am, 2018, 32(3):371-386. doi: 10.1016/j.hoc.2018.01.002 [11] Fillon M. Exploring the causes of chronic cancer pain and possible remedies[J]. CA Cancer J Clin, 2020, 70(2):75-76. doi: 10.3322/caac.21594 [12] Ogez D, Aramideh J, Mizrahi T, et al. Does practising hypnosis-derived communication techniques by oncology nurses translate into reduced pain and distress in their patients? An exploratory study[J]. Br J Pain, 2021, 15(2):147-154. doi: 10.1177/2049463720932949 [13] Elkins GR, Rhodes JR, Biggs ML, et al. Feasibility of attention restoration theory-driven hypnotherapy for fatigue in cancer survivors[J]. Int J Clin Exp Hypn, 2021, 69(2):203-214. doi: 10.1080/00207144.2021.1877088 [14] Montgomery GH, Green JP, Erblich J, et al. Common paraverbal errors during hypnosis intervention training[J]. Am J Clin Hypn, 2021, 63(3):252-268. doi: 10.1080/00029157.2020.1822275 [15] Jong MC, Boers I, van Wietmarschen H, et al. Development of an evidence-based decision aid on complementary and alternative medicine (CAM) and pain for parents of children with cancer[J]. Support Care Cancer, 2020, 28(5):2415-2429. doi: 10.1007/s00520-019-05058-8 -
下载:
点击查看大图
图(1)
计量
- 文章访问数: 106
- HTML全文浏览量: 72
- PDF下载量: 21
- 被引次数: 0
